Thread by @PracticalDeeb

With Dexcom being at the forefront of pumps and CGMs I'm hoping for something special in this one. @ATTDconf #ATTD2021 #dedoc°

Control IQ gave users 2.6 hours additional Time in Range over "Sensor Augmented Pumps" (open loop pump therapy) #ATTD2021 #dedoc°

The number of people getting a Time in Range over 70% tripled with Control-IQ over the open loop therapy group. For long term complication management, this is a great result. #ATTD2021 #dedoc°

Results were largely independent of age. Ages 6 and above were studied. #ATTD2021 #dedoc°

CamAPS achieved similar results with their closed loop system suggesting it is a benefit of closed loop systems in general, rather than a 'secret sauce' in one specific system, vindicating the #WeAreNotWaiting loopers. #ATTD2021 #dedoc°

Nice comparison table of CamAPS to Control-IQ and the 780G. While the Time in Range results were similar, for users who want more or less control, it is great there are now options. #ATTD2021 #dedoc°

Now Omnipod 5, an insulin pump, without tubes, you wear like a CGM. Looping gave 2.6 hours additional Time in Range per day. Again, matching the other systems. #ATTD2021 #dedoc°

Now talking about the G7 CGM (we're barely at G6 in Australia!). #ATTD2021 #dedoc°

The question immediately coming to me as the speaker goes through the features is "but can you change the battery?" #ATTD2021 #dedoc°

The G7 is a sensor and transmitter in 1 which means no more expensive transmitter purchases. does this mean they will increase the unit price to cover the shortfall? #ATTD2021 #dedoc°